Gastrointestinal Cancers: Clinical Trials

36 trials for Gastrointestinal Cancers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 11 recruiting, 4 not yet recruiting, 3 terminated. 12 Not applicable, 8 Phase 2, 3 Phase 1, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable12Recruiting 5, Completed 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 28Recruiting 4, Completed 3, Unknown 1
Phase 13Completed 2, Recruiting 1
Phase 32Not yet recruiting 1, Recruiting 1
Phase 41Terminated 1

Follow Gastrointestinal Cancers: new trials by email Literature Review of Gastrointestinal Cancers trials Research Report on Gastrointestinal Cancers

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multicenter Prospective Observational Cohort Study for Digestive Tract Tumor Screening Using Multi-Target Blood and Fecal Biomarkers
Gastrointestinal Cancers
RecruitingXijing Hospital50002026-08-102026-08-18
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
BHB810 - Gastric Cancer, Gastric Adenocarcinoma
Phase 1 / Phase 2RecruitingBigHat Biosciences, Inc.1642026-07-162026-10-20
Safety and Efficacy of NOM and OPFS Versus RO for dMMR/MSI-H or POLE-Mutated Gastrointestinal Cancers
NOM/OPFS - Gastrointestinal Cancers, Gastrointestinal Cancers - Stomach
Not yet recruitingPeking University Cancer Hospital & Institute222026-07-152026-06-11
Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery
DESIRE: AI-Based Clinical Decision Support for Postoperative Rehabilitation Planning - Oncologic Surgery, Gastrointestinal Cancers
Not applicableNot yet recruitingErasmus Medical Center1032026-06-012026-02-12
Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
Rina-S - Gastrointestinal Cancers
Phase 2RecruitingGenmab1602026-05-112026-10-06
A Randomized, Double-blind, Placebo-controlled, Prospective, Multi-center Trial Evaluating the Improvement of Nutritional Status and Sarcopenia With Silkworm Pupa Tablets in Patients With Malignancies
Silkworm pupa tablets, Placebo - Nutritional Deficiency, Gastrointestinal Cancers
Phase 3Not yet recruitingFirst Affiliated Hospital of Zhejiang University4802026-04-012026-04-28
Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes
18F-FDG, [18F]F-PDL1-3 - Lung Cancer (NSCLC), Cervical Squamous Cell Cancer
Phase 2RecruitingPeking University Cancer Hospital & Institute502026-02-012026-09-29
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Adebrelimab - Non-Small Cell Lung Cancer, Small Cell Lung Cancer
Not yet recruitingTianjin First Central Hospital3002025-09-152025-09-15
Impact of Glycemic Variability on People With Gastrointestinal Cancer and Diabetes After Surgery
CARE program, Usual Care - Diabetes Melletus, Gastrointestinal Cancers
Not applicableActive not recruitingNational Taiwan University Hospital2602025-09-082025-09-18
Predictive Value of Preoperative Rectus and Diaphragm Muscle Thickness for Postoperative Complications in Gastrointestinal Cancer Surgery
Ultrasonography (Rectus and diaphragma muscle thickness measurement) - Gastrointestinal Cancers, Complication
CompletedAnkara Oncology Research and Training Hospital1292025-09-012026-05-13
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
CYTALUX™ (pafolacianine) injection preoperatively - Esophageal Cancer, Gastrointestinal Cancers
Phase 2RecruitingJohn Waters502025-08-192026-06-05
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
Priming Survey - Lung Cancers, Gastrointestinal Cancers
Not applicableCompletedAbramson Cancer Center at Penn Medicine402025-07-212026-03-04
Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers
Entecavir - Gastrointestinal Cancers
Phase 3RecruitingSun Yat-sen University1362025-05-152025-05-11
FRAIL and FiND for Chemotherapy Toxicity in GI Cancer
No Intervention - Gastrointestinal Cancers, Frailty at Older Adults
CompletedAnkara Etlik City Hospital1222025-05-022026-10-19
Feasibility Study of CBCT for IGRT in Cancer Patients
Comparison of HyperSight CBCT imaging to conventional CBCT imaging. - Head and Neck Cancers, Breast Cancer
Not applicableRecruitingVarian, a Siemens Healthineers Company502025-02-192026-03-13
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
Local Anesthesia, Laparoscopic Transversus Abdominis Plane block - Oncologic Surgery, Cancer
Not applicableRecruitingAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)482025-02-052025-09-18
Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome
True electroacupuncture + True self-administered acupressure, Doctor-prescribed treatment, Sham electroacupuncture + Sham self-administered acupressure - Capecitabine, Hand-foot Syndrome
Not applicableRecruitingAffiliated Hospital of Qinghai University2202024-10-082024-12-12
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Implementation of social determinants of health screening and referral - Cancer, Cancer Survivors
Not applicableRecruitingBarbara Ann Karmanos Cancer Institute1202024-09-032025-08-26
TENS and Compression for Established Oxaliplatin-Induced Peripheral Neuropathy
TENS, Compression Garments, Sequential TENS Plus Compression - CIPN - Chemotherapy-Induced Peripheral Neuropathy, Gastrointestinal Cancers
Not applicableCompletedCumhuriyet University1402024-08-022026-09-09
Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers
Electronic Patient Reported Outcomes platform, Health Related Quality of Life Surveys - Gastrointestinal Cancers, Gastrointestinal Cancer Metastatic
Not applicableWithdrawnUniversity of California, San Francisco2024-06-152024-05-08

Showing 20 of 36. Sign in to see all of them.

Narrower conditions

Gastrointestinal Neoplasms (36)  ·  Breast Neoplasms (6)  ·  Colorectal Neoplasms (6)  ·  Lung Neoplasms (5)  ·  Neoplasms (5)  ·  Melanoma (4)  ·  Stomach Neoplasms (4)  ·  Carcinoma, Non-Small-Cell Lung (3)  ·  Head and Neck Neoplasms (3)  ·  Pancreatic Neoplasms (3)  ·  Biliary Tract Neoplasms (2)  ·  Brain Neoplasms (2)  ·  Esophageal Neoplasms (2)  ·  Frailty (2)  ·  Liver Neoplasms (2)

Broader conditions

Digestive System Diseases (36)  ·  Digestive System Neoplasms (36)  ·  Gastrointestinal Diseases (36)  ·  Neoplasms by Site (36)  ·  Neoplasms (31)  ·  Neoplasms by Histologic Type (9)  ·  Respiratory Tract Diseases (8)  ·  Colonic Diseases (7)  ·  Intestinal Diseases (7)  ·  Intestinal Neoplasms (7)  ·  Lung Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Respiratory Tract Neoplasms (7)  ·  Thoracic Neoplasms (7)  ·  Breast Diseases (6)

Interventions

Anesthesia, Local (1)  ·  Bevacizumab (1)  ·  Erlotinib Hydrochloride (1)  ·  Everolimus (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Gastrectomy (1)  ·  Gefitinib (1)  ·  Hyperthermic Intraperitoneal Chemotherapy (1)  ·  Imatinib Mesylate (1)  ·  Ketamine (1)  ·  Pafolacianine (1)  ·  Proctectomy (1)  ·  Psychotherapy (1)  ·  Quality of Life (1)  ·  Radiosurgery (1)

Sponsors

Ankara Etlik City Hospital (2)  ·  Peking University Cancer Hospital & Institute (2)  ·  Sun Yat-sen University (2)  ·  AIO-Studien-gGmbH (1)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Affiliated Hospital of Qinghai University (1)  ·  Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1)  ·  Ankara Oncology Research and Training Hospital (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Bay Area Gynecology Oncology (1)  ·  BigHat Biosciences, Inc. (1)  ·  Brian Anderson, MD (1)  ·  Brigette Ma (1)  ·  Cumhuriyet University (1)  ·  Dana-Farber Cancer Institute (1)

Countries

United States (16)  ·  China (6)  ·  Turkey (Türkiye) (4)  ·  Netherlands (2)  ·  Australia (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Japan (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Galip Can Uyar, MD (2)  ·  Alix G Sleight, PhD, OTD, MPH, OTR/L (1)  ·  Anne E Belcher, PhD (1)  ·  Brian T Anderson, MD (1)  ·  Casey Allen, MD (1)  ·  Edward Giovannucci, MD, ScD (1)  ·  Gary G Bennett, PhD (1)  ·  Hsuan-Ju Kuo, PhD (1)  ·  Hua Zhu (1)  ·  James B Yu, MD (1)  ·  James Lilja, MD (1)  ·  John Waters, M.D. (1)  ·  Karin Jordan, Dr. med. (1)  ·  Neeta Venepalli, MD (1)  ·  Steven A Rosenberg, M.D. (1)

Results publications

PMID 23487599, PMID 24327720, PMID 24368437, PMID 24657333, PMID 24974387, PMID 25447852, PMID 25514302, PMID 26858840

NIH funding

2025 (1), K01HD110719 (1)